Cipla Receives US FDA Approval For Generic Nexium

Cipla Receives US FDA Approval For Generic Nexium

By, Admin 27 March 2020

Cipla Limited announced that it has received final approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for esomeprazole for oral suspension 10mg, 20mg and 40mg. Cipla is the first company to file for the 10mg strength.Cipla's Esomeprazole for oral suspension 10mg, 20mg and 40mg is AB rated generic therapeutic equivalent version of AstraZeneca Pharmaceutical's Nexium.It is a proton pump inhibitor indicated for the treatment of gastroesophageal reflux disease (GERD), risk reduction of NSAID-associated gastric ulcer, H pylori eradication to reduce the risk of duodenal ulcer recurrence and pathological hypersecretory conditions, including Zollinger-Ellison syndrome.According to IQVIA (IMS Health), Nexium and its generic equivalents had US sales of approximately $70 million for the 12 month period ending November 2019. The product is available for shipping immediately

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!